GoodRx Holdings, Inc. - Class A Common Stock (GDRX)

Q3 2023 13F Holders as of 9/30/2023

Type / Class
Equity / Class A Common Stock
Shares outstanding
108M
Number of holders
149
Total 13F shares, excl. options
138M
Shares change
+3.81M
Total reported value, excl. options
$774M
Value change
+$21.6M
Put/Call ratio
0.98
Number of buys
73
Number of sells
-68
Price
$5.63

Significant Holders of GoodRx Holdings, Inc. - Class A Common Stock (GDRX) as of Q3 2023

188 filings reported holding GDRX - GoodRx Holdings, Inc. - Class A Common Stock as of Q3 2023.
GoodRx Holdings, Inc. - Class A Common Stock (GDRX) has 149 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 138M shares .
Largest 10 shareholders include Francisco Partners Management, LP (84.7M shares), VANGUARD GROUP INC (8.68M shares), Silver Lake Group, L.L.C. (3.53M shares), RENAISSANCE TECHNOLOGIES LLC (2.74M shares), AMERIPRISE FINANCIAL INC (2.63M shares), Petrus Trust Company, LTA (2.2M shares), BlackRock Inc. (1.85M shares), MORGAN STANLEY (1.74M shares), SQN Investors LP (1.66M shares), and Technology Crossover Management X, Ltd. (1.65M shares).
This table shows the top 149 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.